🇺🇸 FDA
Pipeline program

TV46017

TV46017-COPD-10046

Phase 1 small_molecule terminated

Quick answer

TV46017 for Chronic Obstructive Pulmonary Disease (COPD is a Phase 1 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Chronic Obstructive Pulmonary Disease (COPD
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials